Comparison of the effects of sertraline and agomelatine on sleep quality, sexual functioning and metabolic parameters in patients with major depressive disorder

References

• Corruble E, de Bodinat C, Belaïdi C, et al. Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial. Int J Neuropsychopharmacol. 2013;16:2219–2234. doi: 10.1017/S1461145713000679
   PubMed Web of Science ®Google Scholar
• Hale A, Corral RM, Mencacci C, et al. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. Int Clin Psychopharmacol. 2010;25:305–314. doi: 10.1097/YIC.0b013e32833a86aa
   PubMed Web of Science ®Google Scholar
• Kasper S, Hajak G, Wulff K, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry. 2010;71:109–120. doi: 10.4088/JCP.09m05347blu
   PubMed Web of Science ®Google Scholar
• Guaiana G, Gupta S, Chiodo D, et al. Agomelatine versus other antidepressive agents for major depression. Cochrane Database Syst Rev. 2013;17(12):CD008851.
   Google Scholar
• Akpınar E, Cerit C, Talas A, et al. Agomelatine versus sertraline: an observational, open-labeled and 12 weeks follow-up study on efficacy and tolerability. Clin Psychopharmacol Neurosci. 2016;14:351–356. doi: 10.9758/cpn.2016.14.4.351
   Web of Science ®Google Scholar
• Kasper S, Corruble E, Hale A, et al. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control. Int Clin Psychopharmacol. 2013;28:12–19. doi: 10.1097/YIC.0b013e328359768e
   PubMed Web of Science ®Google Scholar
• Huang KL, Lu WC, Wang YY, et al. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials. Aust N Z J Psychiatry. 2014;48:663–671. doi: 10.1177/0004867414525837
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Corruble E, Hale A, et al. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline. CNS Spectr. 2013;18:163–170. doi: 10.1017/S1092852913000060
   PubMed Web of Science ®Google Scholar
• Quera-Salva MA, Hajak G, Philip P, et al. Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients. Int Clin Psychopharmacol. 2011;26:252–262. doi: 10.1097/YIC.0b013e328349b117
   PubMed Web of Science ®Google Scholar
• Montejo A, Majadas S, Rizvi SJ, et al. The effects of agomelatine on sexual function in depressed patients and healthy volunteers. Hum Psychopharmacol. 2011;26:537–542. doi: 10.1002/hup.1243
   PubMed Web of Science ®Google Scholar
• Montejo AL, Deakin JF, Gaillard R, et al. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. J Psychopharmacol. 2015;29:1119–1128. doi: 10.1177/0269881115599385
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Sharma MS, Brunoni AR, et al. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85:270–288. doi: 10.1159/000447034
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JK, Konarski JZ, et al. The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opin Drug Saf. 2006;5:523–537. doi: 10.1517/14740338.5.4.523
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Vigo DE. Melatonin, mitochondria, and the metabolic syndrome. Cell Mol Life Sci. 2017;74:3941–3954. doi: 10.1007/s00018-017-2611-0
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Hardeland R. Inflammaging metabolic syndrome and melatonin: a call for treatment studies. Neuroendocrinology. 2017;104:382–397. doi: 10.1159/000446543
   Web of Science ®Google Scholar
• Karaiskos D, Tzavellas E, Ilias I, et al. Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus. Int J Clin Pract. 2013;67:257–260. doi: 10.1111/ijcp.12112
   PubMed Web of Science ®Google Scholar
• Hayasaka Y, Purgato M, Magni LR, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179–184. doi: 10.1016/j.jad.2015.03.021
   PubMed Web of Science ®Google Scholar
• McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26:25–40. doi: 10.1080/009262300278623
   PubMed Web of Science ®Google Scholar
• Soykan A. The reliability and validity of Arizona Sexual Experiences Scale in Turkish ESRD patients undergoing hemodialysis. Int J Impot Res. 2004;16:531–534. doi: 10.1038/sj.ijir.3901249
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4
   PubMed Web of Science ®Google Scholar
• Ağargün MY, Kara H, Anlar Ö. Pittsburgh Uyku Kalitesi İndeksi’nin Geçerliği Ve Güvenirliği. Turk Psikiyatr Derg. 1996;7:107–115.
   Google Scholar
• Quera Salva MA, Hartley S, Barbot F, et al. Circadian rhythms, melatonin and depression. Curr Pharm Des. 2011;17:1459–1470. doi: 10.2174/138161211796197188
   PubMed Web of Science ®Google Scholar
• Robillard R, Oxley C, Hermens DF, et al. The relative contributions of psychiatric symptoms and psychotropic medications on the sleep-wake profile of young persons with anxiety, depression and bipolar disorders. Psychiatry Res. 2016;243:403–406. doi: 10.1016/j.psychres.2016.06.025
   PubMed Web of Science ®Google Scholar
• Sapetti A. Agomelatine: an antidepressant without deterioration of sexual response. J Sex Marital Ther. 2012;38:190–197. doi: 10.1080/0092623X.2011.613095
   PubMed Web of Science ®Google Scholar
• Reichenpfader U, Gartlehner G, Morgan LC, et al. Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis. Drug Saf. 2014;37:19–31. doi: 10.1007/s40264-013-0129-4
   PubMed Web of Science ®Google Scholar
• Bella AJ, Shamloul R. Psychotropics and sexual dysfunction. Cent European J Urol. 2013;66:466–471.
   Google Scholar
• Clayton AH, El Haddad S, Iluonakhamhe JP, et al. Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opin Drug Saf. 2014;13:1361–1374. doi: 10.1517/14740338.2014.951324
   PubMed Web of Science ®Google Scholar
• Wei F, Crain AL, Whitebird RR, et al. Effects of paroxetine and sertraline on low-density lipoprotein cholesterol: an observational cohort study. CNS Drugs. 2009;23:857–865. doi: 10.2165/11310840-000000000-00000
   Web of Science ®Google Scholar
• Beyazyüz M, Albayrak Y, Eğilmez OB, et al. Relationship between SSRIs and metabolic syndrome abnormalities in patients with generalized anxiety disorder: a prospective study. Psychiatry Investig. 2013;10:148–154. doi: 10.4306/pi.2013.10.2.148
   Web of Science ®Google Scholar
• Voican CS, Corruble E, Naveau S, et al. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry. 2014;171:404–415. doi: 10.1176/appi.ajp.2013.13050709
   PubMed Web of Science ®Google Scholar
• Freiesleben SD, Furczyk K. A systematic review of agomelatine-induced liver injury. J Mol Psychiatry. 2015;3:1484. doi: 10.1186/s40303-015-0011-7
   Google Scholar
• Medvedev VE. Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE. Neuropsychiatr Dis Treat. 2017;13:1141–1151. doi: 10.2147/NDT.S129793
   PubMed Web of Science ®Google Scholar